vs
Side-by-side financial comparison of MEDIFAST INC (MED) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $75.1M, roughly 1.9× MEDIFAST INC). On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-7.8M). Over the past eight quarters, Purple Innovation, Inc.'s revenue compounded faster (8.3% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
MED vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $140.7M |
| Net Profit | — | $-3.2M |
| Gross Margin | 69.4% | 41.9% |
| Operating Margin | -10.4% | -1.6% |
| Net Margin | — | -2.3% |
| Revenue YoY | -36.9% | 9.1% |
| Net Profit YoY | — | 62.1% |
| EPS (diluted) | $-1.64 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $140.7M | ||
| Q3 25 | $89.4M | $118.8M | ||
| Q2 25 | $105.6M | $105.1M | ||
| Q1 25 | $115.7M | $104.2M | ||
| Q4 24 | $119.0M | $129.0M | ||
| Q3 24 | $140.2M | $118.6M | ||
| Q2 24 | $168.6M | $120.3M | ||
| Q1 24 | $174.7M | $120.0M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-2.3M | $-11.7M | ||
| Q2 25 | $2.5M | $-17.3M | ||
| Q1 25 | $-772.0K | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $1.1M | $-39.2M | ||
| Q2 24 | $-8.2M | $27.0K | ||
| Q1 24 | $8.3M | $-50.2M |
| Q4 25 | 69.4% | 41.9% | ||
| Q3 25 | 69.5% | 42.8% | ||
| Q2 25 | 72.6% | 35.9% | ||
| Q1 25 | 72.8% | 39.4% | ||
| Q4 24 | 74.1% | 42.9% | ||
| Q3 24 | 75.4% | 29.7% | ||
| Q2 24 | 73.2% | 40.7% | ||
| Q1 24 | 72.8% | 34.8% |
| Q4 25 | -10.4% | -1.6% | ||
| Q3 25 | -4.6% | -10.2% | ||
| Q2 25 | -1.0% | -13.5% | ||
| Q1 25 | -1.1% | -13.9% | ||
| Q4 24 | 0.6% | -6.0% | ||
| Q3 24 | 1.5% | -39.5% | ||
| Q2 24 | -4.7% | -12.1% | ||
| Q1 24 | 4.5% | -19.3% |
| Q4 25 | — | -2.3% | ||
| Q3 25 | -2.5% | -9.9% | ||
| Q2 25 | 2.3% | -16.5% | ||
| Q1 25 | -0.7% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | 0.8% | -33.1% | ||
| Q2 24 | -4.8% | 0.0% | ||
| Q1 24 | 4.8% | -41.8% |
| Q4 25 | $-1.64 | $0.03 | ||
| Q3 25 | $-0.21 | $0.11 | ||
| Q2 25 | $0.22 | $0.16 | ||
| Q1 25 | $-0.07 | $0.18 | ||
| Q4 24 | $0.08 | $0.08 | ||
| Q3 24 | $0.10 | $0.36 | ||
| Q2 24 | $-0.75 | $0.00 | ||
| Q1 24 | $0.76 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $198.9M | $-29.7M |
| Total Assets | $248.0M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $24.3M | ||
| Q3 25 | $173.5M | $32.4M | ||
| Q2 25 | $162.7M | $34.2M | ||
| Q1 25 | $164.6M | $21.6M | ||
| Q4 24 | $162.3M | $29.0M | ||
| Q3 24 | $170.0M | $23.4M | ||
| Q2 24 | $163.5M | $23.4M | ||
| Q1 24 | $156.4M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $198.9M | $-29.7M | ||
| Q3 25 | $214.7M | $-26.9M | ||
| Q2 25 | $216.0M | $-15.6M | ||
| Q1 25 | $211.0M | $1.3M | ||
| Q4 24 | $210.1M | $20.2M | ||
| Q3 24 | $207.3M | $28.0M | ||
| Q2 24 | $205.3M | $66.4M | ||
| Q1 24 | $211.0M | $65.5M |
| Q4 25 | $248.0M | $296.3M | ||
| Q3 25 | $268.2M | $302.1M | ||
| Q2 25 | $269.3M | $303.8M | ||
| Q1 25 | $280.0M | $293.8M | ||
| Q4 24 | $284.2M | $307.8M | ||
| Q3 24 | $291.2M | $309.3M | ||
| Q2 24 | $293.5M | $362.1M | ||
| Q1 24 | $302.8M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $-5.8M |
| Free Cash FlowOCF − Capex | $-6.6M | $-7.8M |
| FCF MarginFCF / Revenue | -8.8% | -5.5% |
| Capex IntensityCapex / Revenue | 1.8% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $-5.8M | ||
| Q3 25 | $12.1M | $-968.0K | ||
| Q2 25 | $-3.4M | $-4.0M | ||
| Q1 25 | $3.4M | $-23.1M | ||
| Q4 24 | $-4.9M | $6.8M | ||
| Q3 24 | $9.1M | $1.1M | ||
| Q2 24 | $13.1M | $-8.9M | ||
| Q1 24 | $7.3M | $-16.8M |
| Q4 25 | $-6.6M | $-7.8M | ||
| Q3 25 | $10.8M | $-1.8M | ||
| Q2 25 | $-4.8M | $-7.0M | ||
| Q1 25 | $1.9M | $-25.3M | ||
| Q4 24 | $-7.2M | $5.7M | ||
| Q3 24 | $7.7M | $101.0K | ||
| Q2 24 | $11.1M | $-11.0M | ||
| Q1 24 | $5.4M | $-19.9M |
| Q4 25 | -8.8% | -5.5% | ||
| Q3 25 | 12.0% | -1.5% | ||
| Q2 25 | -4.5% | -6.6% | ||
| Q1 25 | 1.6% | -24.3% | ||
| Q4 24 | -6.1% | 4.4% | ||
| Q3 24 | 5.5% | 0.1% | ||
| Q2 24 | 6.6% | -9.2% | ||
| Q1 24 | 3.1% | -16.5% |
| Q4 25 | 1.8% | 1.4% | ||
| Q3 25 | 1.5% | 0.7% | ||
| Q2 25 | 1.3% | 2.8% | ||
| Q1 25 | 1.3% | 2.2% | ||
| Q4 24 | 1.9% | 0.8% | ||
| Q3 24 | 1.0% | 0.9% | ||
| Q2 24 | 1.1% | 1.7% | ||
| Q1 24 | 1.1% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
